How Does “Bioavailability” Apply to CBD’s consumption?

We’ve now discussed the meaning of “bioavailability” (https://bit.ly/339g9rU); now how does this apply to CBD’s various forms of consumption (https://bit.ly/2ngcMQA)?

Sublingual: Being only degraded by enzymes in the mouth’s saliva, #bioavailability in using a tincture is found to be 12-35% per a 2012 study (https://www.ncbi.nlm.nih.gov/pubmed/22716155).

Topical: Applied to the skin, #CBD lotions and salves never reach the bloodstream; meaning technically, they have a 0% bioavailability. Rather, skin pores absorb the CBD, allowing interaction with cannabinoid receptors nearby and providing targeted healing.

Inhalation: Smokeable and vaporizable CBD products directly enter the lungs, transferring to the bloodstream with lowered breakdown rates. Multiple studies have been conducted, finding 34-46% bioavailability, and as high as 56% bioavailability (https://www.ncbi.nlm.nih.gov/pubmed/20545522)

Ingestion: Passing through metabolic and digestive systems, a 4-20% bioavailability was founded by a 2009 study (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/)

Surprised by these facts? Well, wait until we tell you about the upcoming, game-changing #TruPura CBD Gel Tabs…